Akari Therapeutics Plc (AKTX)
8.18
-0.66
(-7.47%)
USD |
NASDAQ |
Oct 16, 16:00
8.11
-0.07
(-0.86%)
After-Hours: 20:00
Akari Therapeutics Free Cash Flow : -10.74M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.74M |
| March 31, 2026 | -10.93M |
| December 31, 2025 | -10.59M |
| September 30, 2025 | -9.678M |
| June 30, 2025 | -9.066M |
| March 31, 2025 | -10.66M |
| December 31, 2024 | -12.55M |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| March 31, 2023 | |
| June 30, 2022 | -20.19M |
| March 31, 2022 | -16.48M |
| December 31, 2021 | -18.85M |
| September 30, 2021 | -18.08M |
| June 30, 2021 | -17.22M |
| March 31, 2021 | -16.63M |
| December 31, 2020 | -16.95M |
| September 30, 2020 | -16.18M |
| Date | Value |
|---|---|
| June 30, 2020 | -20.39M |
| March 31, 2020 | -20.89M |
| December 31, 2019 | -12.92M |
| September 30, 2019 | -14.02M |
| June 30, 2019 | -14.44M |
| March 31, 2019 | -17.95M |
| December 31, 2018 | -22.58M |
| September 30, 2018 | -26.53M |
| June 30, 2018 | -30.41M |
| March 31, 2018 | -26.86M |
| December 31, 2017 | -31.64M |
| September 30, 2017 | -29.51M |
| June 30, 2017 | -25.30M |
| March 31, 2017 | -26.65M |
| December 31, 2016 | -24.57M |
| September 30, 2016 | -24.95M |
| June 30, 2016 | -14.78M |
| March 31, 2016 | -10.01M |
| December 31, 2015 | -4.975M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| DBV Technologies SA | -152.18M |
| Cellectis SA | -45.36M |
| Bicycle Therapeutics Plc | -207.47M |
| argenx SE | 1.090B |
| Autolus Therapeutics Plc | -240.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.112M |
| Cash from Financing (Quarterly) | 8.034M |
| Free Cash Flow Per Share (Quarterly) | -1.737 |
| Free Cash Flow to Equity (Quarterly) | -3.073M |
| Free Cash Flow to Firm (Quarterly) | -3.032M |
| Free Cash Flow Yield | -96.21% |